文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
出版信息
JAMA. 2001;285(20):2572-3.
PMID:
11396466
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2025
相似文献
1
From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
JAMA. 2001;285(20):2572-3.
2
Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
MMWR Morb Mortal Wkly Rep. 2001 Apr 20;50(15):289-91.
3
Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
Can Commun Dis Rep. 2001 Jul 1;27(13):114-6.
4
From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.
JAMA. 2002 Dec 18;288(23):2967. doi: 10.1001/jama.288.23.2967-jwr1218-6-1.
5
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.
MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):998-9.
6
From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
JAMA. 2001 Sep 26;286(12):1445-6.
7
Rifampin plus pyrazinamide-induced hepatitis requiring hospitalization in a 30-y-old male with latent tuberculosis.
Scand J Infect Dis. 2005;37(2):155-7.
8
National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection.
Clin Infect Dis. 2005 Oct 15;41(8):1125-33. doi: 10.1086/444463. Epub 2005 Sep 9.
9
Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?
Am J Respir Crit Care Med. 2003 Mar 15;167(6):809-10. doi: 10.1164/rccm.2301002.
10
Rifampin and pyrazinamide for treatment of latent tuberculosis infection.
Clin Infect Dis. 2006 Mar 15;42(6):892; author reply 892-3. doi: 10.1086/500458.
引用本文的文献
1
The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China.
Front Pharmacol. 2021 May 10;12:657805. doi: 10.3389/fphar.2021.657805. eCollection 2021.
2
Updates on the risk factors for latent tuberculosis reactivation and their managements.
Emerg Microbes Infect. 2016 Feb 3;5(2):e10. doi: 10.1038/emi.2016.10.
3
Antitubercular therapy in patients with cirrhosis: challenges and options.
World J Gastroenterol. 2014 May 21;20(19):5760-72. doi: 10.3748/wjg.v20.i19.5760.
4
Hepatotoxic effects of therapies for tuberculosis.
Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):543-56. doi: 10.1038/nrgastro.2010.134. Epub 2010 Aug 31.